Eli Lilly Fights Consolidation Bid For Cymbalta Suit
Eli Lilly & Co. told the U.S. Judicial Panel on Multidistrict Litigation Friday to uphold its decision not to consolidate suits over the alleged withdrawal risks of its antidepressant Cymbalta, arguing...To view the full article, register now.
Already a subscriber? Click here to view full article